Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
about
Follicular delivery of spironolactone via nanostructured lipid carriers for management of alopecia.Multifunction hexagonal liquid-crystal containing modified surface TiO2 nanoparticles and terpinen-4-ol for controlled release.Nanostructured lipid carriers for oral bioavailability enhancement of raloxifene: Design and in vivo study.Application of nanotechnology in improving bioavailability and bioactivity of diet-derived phytochemicals.Nanostructured lipid carriers system: recent advances in drug delivery.Nanostructured lipid carriers and their current application in targeted drug delivery.Process optimization and photostability of silymarin nanostructured lipid carriers: effect on UV-irradiated rat skin and SK-MEL 2 cell line.Nanostructured Lipid Carriers (NLC)-Based Gel for the Topical Delivery of Aceclofenac: Preparation, Characterization, and In Vivo EvaluationFormulation and evaluation of optimized oxybenzone microsponge gel for topical delivery.Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks.Nanostructured lipid carriers (NLC) based controlled release topical gel of clobetasol propionate: design and in vivo characterization.Rice bran and raspberry seed oil-based nanocarriers with self-antioxidative properties as safe photoprotective formulations.Oral bioavailability enhancement of agomelatine by loading into nanostructured lipid carriers: Peyer's patch targeting approach.Development and assessment of stable formulations containing two herbal antimicrobials: Allium sativum L. and Eruca sativa miller seed oils.Ocular Delivery System for Propranolol Hydrochloride Based on Nanostructured Lipid Carrier.
P2860
Q34610568-13C25870-61A0-47AC-A17A-8ED941F09AF0Q35024311-D5EBDA49-EC21-4DFB-994E-170830E7A865Q36870135-28737E22-758F-41DE-8E80-5E27228579C3Q37646827-BD52742C-A137-45C5-95BD-2829CCEDAA22Q38038902-C8D37BFF-6E7C-4E53-81F7-E6D1C5B0FEABQ38210565-BAD6B32F-37CE-4F01-B8CD-3CF1464D811BQ38757246-1908E40A-BBBE-479D-8D1E-545CE91B47CCQ42276924-2F1B9DAC-C528-477F-AB9B-507F5D2D5B61Q43173993-D1A9A548-4BB6-4829-BA29-4B673FAB3F4DQ48273811-6AAF1C1A-4764-477E-BC7F-233993952C60Q50668416-A7D2DCA8-C65A-4DA6-9FB9-8189129A39EFQ51750668-63F6A3EC-5752-4765-8077-1974F7E91B03Q52624809-C2AA81F4-2C5E-4FAE-B8FB-FACF24893D32Q53786297-4748D7B3-A146-45AD-84BC-2C4339BB492BQ55471051-3E126B30-B9EC-432D-9A97-F719BC99656B
P2860
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
description
2010 nî lūn-bûn
@nan
2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
name
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@ast
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@en
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers
@nl
type
label
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@ast
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@en
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers
@nl
prefLabel
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@ast
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@en
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers
@nl
P2093
P2860
P1433
P1476
Formulation of a novel oxybenzone-loaded nanostructured lipid carriers (NLCs)
@en
P2093
Alia A Badawi
Rania A Sanad
Tahany S Elbayoomy
P2860
P2888
P304
P356
10.1208/S12249-010-9553-2
P407
P577
2010-11-24T00:00:00Z
P5875
P6179
1000417757